Alkami director granted 457 deferred shares
FOX JEFFREY H reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FOX JEFFREY H reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Jeffrey H. Fox received a grant of 457 shares of Common Stock as compensation, recorded at a price of $0.00 per share. After this award, he directly holds 20,780 shares. According to the footnote, he elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 457 | $0.00 | $0.00 |
Footnotes (1)
- F1. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan.
Key Figures
Key Terms
2021 Incentive Award Plan financial
Common Stock financial
Grant, award, or other acquisition financial
defer receipt financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Alkami Technology (ALKT) director Jeffrey H. Fox report on this Form 4?
Was Jeffrey H. Fox’s Alkami (ALKT) stock grant an open-market purchase?
Is the Form 4 transaction for Jeffrey H. Fox in Alkami (ALKT) a buy or a sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.